Digital microfluidics
With the rise of theranostics and personalized medicine, medical centers are increasingly in need of a wider variety of specialized radiotracers—tracers that can be produced on-site in small quantities, tailored specifically for individual patients. To meet this growing demand, a digital microfluidic automation system designed for radiopharmaceutical synthesis has been developed, perfectly suited for both research and preclinical stages.
Microfluidic environment
- Reagent and precursor consumption is 90% lower than normal.
- Faster response efficiency
- Multiple parallel reaction channels
The digital microfluidic automated radiopharmaceutical synthesis system, installed in a hot cell and paired with radioactive isotope sources, serves as a versatile tool for developing and producing radiotracers in a uniquely innovative microfluidic environment. Thanks to microfluidic technology, the system requires minimal reagents and precursors, enables rapid synthesis, and offers superior control over process parameters.
Offer flexible work arrangements
- Fully Automatic Mode
- Optional reaction pathway
- Reusable chips
- Controllable temperature, up to 150°C
The digital microfluidic automated radiopharmaceutical synthesis system can perform synthesis in manual mode or carry out fully automatic synthesis.
Synthesize a variety of tracers
- 18 F-Marker Tracer: Al 18 F-NOTA-octreotide, 18 F-water-phase fluorophosphorus compound
- 68 Ga-labeled tracer: 68Ga-DOTA-TP-FAPI
The digital microfluidic automated radiopharmaceutical synthesis system, based on a unique microfluidic column structure, effectively prevents cross-contamination. The following radioactive isotopes have already been successfully used in the digital microfluidic automated radiopharmaceutical synthesis system: 18 F and 68 Yeah.
Patent Name: An Automated Radiopharmaceutical Synthesis System and Method Based on Digital Microfluidics Application Number: CN202510303386.1
©2024 Hangzhou Jirui Technology Co., Ltd. All Rights Reserved